Vivos Inc (QB) (RDGL) 시세

Omg. You are so boring and so predictable. We all get it....you're not a fan of the company. You believe MK is incompetent. How about you save yourself hours upon hours of your life and just stop posting. Just assume we all know what your opinion is. Go out... get some fresh air. Make friends. Make memories. 

$RDGL!!! :) :) :) Helping Humans. 🤍

Your assumption about the worst vs. best patient outcome is speculation, not fact. While it's possible MK highlighted the most promising case first, that doesn’t mean the other four patients fared worse—or that the treatment failed.

1. Occam’s Razor Works Both Ways

You assume MK picked the best patient to “crow about.” But just as easily, he may have chosen the first available 30-day scan or the most representative case.

If the treatment were failing across the board, he wouldn’t highlight any patient at all, as that would backfire.

The simplest explanation? Vivos is following standard clinical reporting—early data points first, with more to come.


2. You’re Ignoring the Other Possibilities

If Vivos were hiding bad results, they wouldn’t be running a transparent clinical trial with regulatory oversight.

Maybe the other patients were treated later and haven’t reached the 30-day scan window yet.

Maybe they had similar outcomes, and MK simply reported the first available case.


3. The Real Test Comes With More Data

We can argue about assumptions all day, but assumptions aren’t data.



Instead of cherry-picking assumptions, let’s wait for the full dataset. That’s how science works—not by making conclusions based on incomplete evidence."


RDGL

Yep, it was a 5 star PR

Some Key Takeaways from today's PR :
1) Safety Confirmed : No reported adverse events in the first 5 patients.

2) Early Efficacy Signs: PET scans show significant tumor reduction and decrease in metastatic activity..

3) Trial Expansion Planned : Proposal to increase from 30 to 50 patients for broader data collection.

4) New Technology : Introduction of a Deep Needle CT guided injection device for targeting deeper tumors like lung and pancreatic cancer.

That was quite the PR today.

You're oversimplifying cancer metabolism and misrepresenting how treatment response is evaluated. Yes, active cancer cells metabolize glucose, but PET scans alone do not distinguish between live cancer cells, inflammation, or post-radiation immune activity.

1. PET Uptake ? Proof of Treatment Failure

Radiation doesn’t kill all cancer cells instantly. Some die immediately, while others undergo delayed apoptosis over weeks to months.

PET scans can show false positives due to radiation-induced inflammation and immune responses—common after Y-90 therapies.

This is why standard oncology protocols use multiple follow-up scans (60, 90, 180 days) before declaring success or failure.


2. MK "Jumping the Gun"? Not Necessarily

Reporting a single 30-day PET scan does not mean he’s making final success claims—it’s an early data point.

The FDA requires step-by-step trial reporting, including preliminary results.

Declaring MK "grossly incompetent" ignores the reality of regulatory hurdles, clinical trial design, and multi-month patient tracking.


3. What Comes Next Matters More

If subsequent PET scans show continued tumor shrinkage, then your argument collapses.

If the tumor still shows metabolic activity at 90+ days without further shrinkage, then additional data is needed to refine dosing or protocol.


Bottom line: It’s premature to call this a failure OR a success at 30 days. The proper scientific approach is to wait for multi-month follow-up results before making definitive claims. Let’s base conclusions on complete data, not just assumptions."

RDGL

"While the trial’s primary objective is to establish safety, these early signs of efficacy are highly encouraging ".
We are in Phase 1. That is the phase to determine safety. 100 % safety results.
The trial is expanding to 50 patients.
Quite the reach to state that a trial has failed in Phase 1 because it has not exhibited 100% safety. AND 100% efficacy.

Sure seems if a cancer cell continues to ferment glucose, as is typical for cancer cells vs. normal cells, hence how F18 labeled glucose lights up cancer but not normal cells for PET scan, that cancer is alive and well. On the other hand, even if I stipulate to all you say about more time is needed to know, that only confirms MK has again jumped the gun with unsubstantiated product performance and safety claims. Either way, MK is again proven a gross incompetent getting Radiogel to market.

As far as how the other 4 patients fared, I'm assuming the one MK chose to crow about had the most positive outcome so far. That is a very safe assumption. Would he crow about the worse outcome and not bother mentioning the better outcomes? That seems very unlikely. Always go with Occam. He's hardly ever wrong.

Wrong.

"Your understanding of tumor response to radiation, especially Yttrium-90 (Y-90) brachytherapy, is incomplete. While it's true that dead tumors don’t uptake F-18 glucose, your conclusion that the treatment failed based solely on a 30-day PET scan is premature and ignores how radiation therapy works over time.

1. Radiation-Induced Tumor Death Takes Time

Y-90 delivers high-dose beta radiation locally, and while some cells die immediately, others undergo delayed apoptosis (programmed cell death) that unfolds over weeks to months.

Clinical studies on Y-90-based therapies (like TheraSphere and SIR-Spheres) show that tumors can continue shrinking for 3-6 months post-treatment, even after Y-90 has fully decayed.



2. 30-Day PET Scan Alone Does Not Confirm Failure

PET scans show glucose metabolism, not necessarily viable cancer cells. Post-radiation inflammation, immune cell activity, and even necrotic tissue can sometimes cause false-positive uptake in the early months.

This is why oncologists don’t declare treatment failure at 30 days—they track progression over multiple scans (60, 90, and even 180 days).



3. No Evidence That “Other Patients Fared Worse”

You're making an unsupported assumption about the other four patients. One report does not equal overall failure, and we don’t have final trial data yet.

The full results, including longer follow-up scans and biopsies, will determine whether the treatment is working.




Conclusion: Declaring failure at 30 days ignores well-established radiation oncology principles. The correct way to assess RadioGel’s effectiveness is long-term tumor response, not an isolated PET scan. Let’s wait for additional data before making sweeping claims."

RDGL

While the trial’s primary objective is to establish safety, these early signs of efficacy are highly encouraging.

After completing the detailed assessment of the available data from the patients, the results will be presented to the Ethics Committee. The lead investigator intends to request authority to increase the study from 30 patients to 50 patients.

Richland, WA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by satisfying the criteria in the Clinical Study Plan, including confirmation via PET imaging that the Y-90 remained at the point of injection and no adverse events reported by any of the initial five patients since the initial treatment date.

Wrong. PET scan showing cancer uptake of F18 labeled glucose lighting up tumor 30 days post treatment is gold standard proof the cancer survived the treatment. Dead tumors don't metabolize anything and don't uptake glucose or F18 labeled glucose. There's no Y90 left now to continue killing the remaining tumor. The surviving portion will grow and spread. The treatment failed at least for the one patient MK chose to report about. Safe to assume the others fared worse.

Patient increase speaks volumes for Radiogels first in-patient results and potential.

Now If Radiogel didn't kill the tumor like Skate said it didn't, would a Lead investigator push for extra patient's to treat in a phase II trial? or would they hold off and revaluate Radiogel disposition? Hmmm ...Boy this is a tuffy.



RDGL

Been here several yrs and aint going nowhere and have just added lots more in the last 6 months to a yr

Yes, very interesting that the investigator didn’t wait to see the results of the 30 before expanding to 50, all he needed to see was the results at only 5 after only 30 days.

Lead investigator even looking to increase patients from 30 to 50 due to the 5 patients bad ass positive results.



RDGL

Soon as the 50-80% flippers are done we’ll move up.

Rdgl did pretty good today and held 10% gains, I'll take 10% any day on any stock.
Still say 15-18 by Friday maybe even more

Perfect dose perfect result. Just ask the lead investigator

Do you know what a phase 1 trial is? The lead investigator loved the results

Tumors are dead, just like your job here. Tumors shrunk 80% in 30 days. In the next 15 days tumor will have shrunk to 95% and in at total of 6 months, tumor will no longer exist in the 5 patients.

Shrunk and shriveled = Dead.



RDGL

Lol you’re too funny, just months ago you were claiming Radiogel would never make it to human trials, and now you’re claiming that the dosage for the very first human trial wasn’t precise enough.

So they screwed up and gave too low a dose, but somehow that confirms safety at proper dose? Again, the delusions with MK's sycophants have no bounds.

So Radiogel does nothing for 5 doomed patients, doesn't even kill the treated tumors, but somehow that confirms Radiogel safety? The delusions here know no bounds.

Even at this lower dose , they got 80 % tumor size reduction and 80% less metastatic activity . Imagine when they play with the doses on these next studies.  And let's not forget we have more indications with the 50 patient studies utilizing the deep needle CT technique 

Agreed......IMO Vivos should be able to tinker with the amount of Radiogel that's infected into the tumor and/or modify the concentration of Y90 in the gel in order to fully destroy the cancerous growth.

This is just a little snippet out of the host of options open to them.

He already knows that. Why do you think he refuses to answer the question about why MK chose cancer of lymph nodes as initial trial. 

Great day.

Now we wait.

The benchmark of the trial is SAFETY.....more reading and less scamming sceeate!!!

(Richland, WA – February 4, 2025) – Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by satisfying the criteria in the Clinical Study Plan, including confirmation via PET imaging that the Y-90 remained at the point of injection and no adverse reported by any of the initial five patients since the initial treatment date.

Do keep yapping about Punts while Vivos keeps scoring Touchdowns. lololsss

False statement. We all know that. The radiogel has been proven to be successful with pets and animals removing the tumor with no reoccurrence. The 90 day report on the five patients will just provide further indication of that. Fact are facts. Another swing and a miss.

An 80% reduction in tumor size in just 30 days  is very promising , especially for a localized cancerous node near the trachea where other treatments can have severe side effects .  The doses will be altered in future studies. Ignore the noise . 

That's not how it works.

Radiogel has killed the tumor and it's on its way out

That's not how it works. You got it wrong again. The tumor is going and the Indian singer is happy

First trial results were to determine safety . 100 % pass 

MK's own update says otherwise. Tumor is still alive metabolizing glucose 30 days post treatment, long after the 10 days or so there's enough Y90 to kill tumor. Tumor survived treatment. Sadly that was apparently the best result. Radiogel failed.

VIVO wins. You lose. Trying to spin a false narrative like CNN won't help. 

Sorry, MK reported this was 30 days post treatment. There's no Y90 left to continue killing tumor. Tumor survived the treatment. And this was his cherry picked best result. Sad.

The more you flail around on here the more you expose yourself Muppet. lololsss

Apparently the Muppet sceeate believes that a trial's initial dosage is always 100% effective on the first attempt.....as a matter of fact, it virtually never does.

Not to mention, once again, that the site chosen ie lymph nodes, had limited to no other treatment option available thus making the 80% reduction in one patient even more incredible.

The scamming clown's narrative is not just ludicrous, its totally idiotic.

Always easy to ignore a question you're afraid to answer.  

The lead investigator likes the results. Lol

You must try harder

Dosimetry looks perfect.

What a whopper of a lie. The tumor is dying. Radiogel killed it

You don't really do science do you. The tumor is disappearing

Great success again..the tumor is going away nicely as expected

The tumor is virtually non-exsitent after 30 days. Like all the other tumors it will be gone.

I bet the Indian singer is shouting from the roof tops